BCL2 and neoplasm: Among the three FL cases with a very low tumor burden (TLA37, TLA39, and TLA42), TLA identified the BCL2‐MBR translocation only in the patient (TLA42) with a quantifiable disease (1E‐05), and no rearrangements were found in those two cases defined as positive but not quantifiable (1E−06 or PNQ).9